The company announced its demonstration timeline while confirming the MQ-9B had completed the platform’s third lifetime test. GA-ASI has progressed its efforts to bring airborne early warning (AEW) ...
GA-ASI, Lockheed Martin, and L3Harris tested connectivity between an MQ-20 Avenger (pictured), and an F-22 fighter. (USAF Test Center) General Atomics Aeronautical Systems, Inc (GA-ASI), Lockheed ...
Fintel reports that on November 24, 2025, BTIG maintained coverage of Cullinan Therapeutics (NasdaqGS:CGEM) with a Buy recommendation. Analyst Price Forecast Suggests 177.65% Upside As of November 17, ...
NEW DELHI/HONG KONG, Nov 19 (Reuters) - Air India is lobbying the Indian government to convince China to let it use a sensitive military airspace zone in Xinjiang to shorten routes as the financial ...
Air India is lobbying the Indian government to convince China to let it use a sensitive military airspace zone in Xinjiang to shorten routes as the financial toll from a ban on Indian carriers flying ...
The latest price target for Cullinan Therapeutics (NASDAQ:CGEM) was reported by BTIG on November 24, 2025. The analyst firm set a price target for $38.00 expecting CGEM to rise to within 12 months (a ...
Shares of LexinFintech Holdings Ltd – ADR (NASDAQ: LX) rose sharply in pre-market trading after reporting third-quarter results. LexinFintech reported quarterly earnings of 43 cents per share, up from ...
The eruption of Mount Semeru in Indonesia has prompted an aviation warning in Australia. The volcano spewed ash into the air more than 2 kilometres higher than the mountain peak on Wednesday. Local ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Danna Lorch You’ll quickly ...
Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are ...
Investing.com - H.C. Wainwright raised its price target on Cullinan Oncology Inc. (NASDAQ:CGEM) to $26.00 from $24.00 on Friday, while maintaining a Buy rating on the stock. The price target increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback